Base to Base Biotech
Jim Cornall
Outreach Signals
Publishing Details
Contact & Outreach
About This Podcast
The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world.
Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed.
The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall.
Base to Base is an Ayr Coastal Media Ltd production.
Podcasting 2.0 Features
Explore Statistics
Recent Episodes
Base to Base biotech podcast 63: Cell and gene therapy logistics, and turning back the Parkinson’s clock
This week, we have a conversation with Mark Sawicki, president and CEO of Cryoport Systems, and we chat with Nick Manusos, CEO of Kenai Therapeutics.Times:03:22 Cryoport Systems22:24 Kenai…
Base to Base biotech podcast 62: A new approach to strokes
This week, we have a conversation with Revalesio president Greg Archambeau about tackling strokes, and other conditions, with a novel method.RevalesioWhile the pharmaceutical industry often focuses…
Base to Base biotech podcast 61: Making tumours visible, and taking on tough challenges
This week, we speak with John Friend, CEO of Kazia Therapeutics; and have a conversation with PureTech Health CEO Robert Lyne and Eric Elenko, president and co-founder of PureTech and acting CEO of…
Base to Base biotech podcast 60: Delivery method reduces prostate cancer tumour size
This week, we have a conversation with the founder, director and chief scientific advisor of Alessa Therapeutics, Pamela Munster.Alessa TherapeuticsAlessa Therapeutics recently announced positive…
Base to Base biotech podcast 59: DIA helping biotech thrive, and Gorlin syndrome
This week, we have a conversation with DIA chief science and regulatory officer, Maria Vassileva, and Medicus Pharma CEO, Raza Bokhari.Times:02:53 Medicus Pharma29:13 DIADIADIA (Drug Information…
Base to Base biotech podcast 58: Congenital myotonic dystrophy
This week, we have a conversation with congenital myotonic dystrophy patient advocacy consultant Lisa Harvey-Duren, who was the founding Myotonic Dystrophy Foundation executive director in 2008, and…
Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression
This week, our conversations are with Uwe Diegel, CEO of Lifeina, about their cooling technologies, and with Dirk Beher, CEO of FundaMental Pharma, about treatment resistant depression.Times:02:37…
Base to Base biotech podcast 56: GRIN genes and relapsing MS
This week, our conversations are with Bruce Leuchter, co-founder, president, CEO of Neurvati Neurosciences and GRIN Therapeutics; and Daniel Vitt, CEO of Immunic.Times:02:54 Immunic24:04 Neurvati…
Base to Base biotech podcast 55: Beating transplant challenges and a circular supply chain
This week, our conversations are with Steve Perrin, president and CSO of Eledon Pharmaceuticals, and Jason Bock, CEO and co-founder of CTMC.Times:03:18 CTMC35:46 Eledon PharmaceuticalsCTMCCTMC is a…
Base to Base biotech podcast 54: Parkinson’s disease and peptides
This week, because April 11 is World Parkinson’s Day, we chat with Dieter Willbold, CSO of Priavoid, and Antje Willuweit, director preclinical development of Priavoid, and Karsten Eastman, CEO and…
Base to Base biotech podcast 53: Diagnosing autism and improving transplant outcomes
On this week’s episode, as April 2 is World Autism Day, we have a conversation with Manish Arora, CEO of LinusBio, on its test that can rule out if someone has autism, and we talk to Thomas Kledal,…
Base to Base biotech podcast 52: Ketamine for depression, and a new company in the kidney disease space
On this week’s episode, we chat with Hans Eriksson, chief medical officer (CMO) of HMNC Brain Health, about ketamine and treatment-resistant depression, and with Krishna Polu, CEO, president and…
Base to Base biotech podcast 51: Ovarian cancer, blue crayfish, and stopping brittle bone disease
On this week’s episode, we chat with Gabriel Levin, gynecologic oncologist at the McGill University Health Centre, and director of oncology at CureLab Oncology Inc., about elanagen, a promising…
Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and drug delivery
As this week’s podcast comes hot on the heels of International Women’s Day and World Kidney Day, which was yesterday, we’ve been able to squeeze them both in. The conversations this week are with…
Base to Base biotech podcast 49: Gene therapy for kidney disease, and using AI to transform diagnostics
This week, we’re chatting with Haseeb Ahmad, CEO of Purespring Therapeutics, about gene therapies in kidney disease, and with Pahini Pandya, Panakeia CEO, about colorectal cancer biomarkers, the…
Base to Base biotech podcast 48: GPCRs and beating neurodegenerative diseases
The conversations on this week’s podcast are with CEO of Merz Therapeutics, Stefan König, about a variety of neurodegenerative conditions and a botulinum neurotoxin, and with CEO of Kainova…
Base to Base biotech podcast 47: Accurate prostate cancer diagnosis and ocular gene therapy
The conversations on this week’s podcast focus on a rapid and accurate prostate cancer diagnostic test, with Valley Diagnostics’ CEO Dave Taylor; and on gene therapy for retinal disease, with Lance…
Base to Base biotech podcast 46: Endometriosis and closing care gaps
The conversations on this week’s podcast are with Vibhor Gupta, director and founder of Pangaea Data, and endogene.bio CEO María Teresa Pérez Zaballos.Times:03:09 Pangaea Data23:43…
Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy
This week, we chat with Affibody CEO David Bejker, and Martin Gleave, founder and chief medical officer at Sustained Therapeutics.Times:03:47 Affibody23:28 Sustained TherapeuticsSustained…
Base to Base biotech podcast 44: Treating breast cancer and how a CDMO and immun0-oncology company collaborate
This week, we chat with Pan Cancer T CEO Dr. Rachel Abbott, about – among other things – triple-negative breast cancer. We also have a conversation with Erik Manting, CEO of immunotherapy company…
Frequently Asked Questions
Base to Base Biotech has published 63 episodes since March 2025, covering topics in Health & Fitness, Life Sciences.
Base to Base Biotech is currently highly active with new episodes weekly. Average episode length is 53m.
Sign up on Grep.FM to access contact details for Base to Base Biotech, including email and social media links.
Similar Podcasts
The Kevin Miller Podcast
Kevin Miller | YAP Media
1,684 episodes
The Dr. Gabrielle Lyon Show
Dr. Gabrielle Lyon
210 episodes
EMS 20/20
Long Pause Media | FlightBridgeED
246 episodes
EM Clerkship
Zack Olson, MD ; Mike Estephan, MD ; Maddie Watts, MD
281 episodes
Psychedelics Today
Psychedelics Today
774 episodes
The Short Coat: An Inside Look at Getting Into and Getting Through Medical School
The Students of the University of Iowa Carver College of Medicine
400 episodes